Implantation of cardioverter defibrillators without induction of ventricular fibrillation

Circulation

Volumn 103, Issue 17, 2001, Pages 2159-2164

  Swerdlow, Charles D ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Defibrillation; Defibrillators, implantable; Shock

Indexed keywords

ADULT; AGED; ARTICLE; DEFIBRILLATOR; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T WAVE;

EID: 0035336187     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.17.2159     Document Type: Article

References (26)

1. Frame R, Brodman R, Furman S, et al. Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing. Pacing Clin Electrophysiol. 1992;15:870-877.
2. Singer I, Lang D. Defibrillation threshold: clinical utility and therapeutic implications. Pacing Clin Electrophysiol. 1992;15:932-949.
3. Vlay SC. Defibrillation threshold testing: necessary but evil? Am Heart J. 1989;117:499-504.
4. Panotopoulos P, Krum D, Axtell K, et al. Ventricular fibrillation sensing and detection by implantable defibrillators: is one better than the others? A prospective, comparative study. J Cardiovasc Electrophysiol. In press.
5. Michelson BI, Igel DA, Wilkoff BL. Adequacy of implantable cardioverter-defibrillator lead placement for tachyarrhythmia detection by sinus rhythm electrogram amplitude. Am J Cardiol. 1995;76:1162-1166.
6. Chen PS, Swerdlow CD, Hwang C, et al. Current concepts of ventricular defibrillation. J Cardiovasc Electrophysiol. 1998;9:553-562.
7. Swerdlow C, Ahem T, Kass R, et al. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter defibrillators. J Am Coll Cardiol. 1996;27:1112-1117.
8. Martin DJ, Chen PS, Hwang C, et al. Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators. J Cardiovasc Electrophysiol. 1997;8:241-248.
9. Swerdlow CD, Peter CT, Kass RM, et al. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability. Circulation. 1997;95:1497-1504.
10. Swerdlow CD, Martin DJ, Kass RM, et al. The zone of vulnerability to T wave shocks in humans. J Cardiovasc Electrophysiol. 1997;8:145-154.
11. Glikson M, Luria D, Friedman PA, et al. Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators? J Cardiovasc Electrophysiol. 2000;11:127-135.
12. Hurst T, Waldecker B. One year experience with a new, steroid eluting, tined defibrillation lead: results of a prospective, randomised, multicentre comparison with a conventional, screw-in defibrillation lead. Eur J Pacing Electrophysiol. 1998;8:11-16.
13. Neuzner J, Liebrich A, Jung J, et al. Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter low-energy Endotak trial. Am J Cardiol. 1999; 83:34D-39D.
14. Raitt MH, Dolack GL, Kudenchuk PJ, et al. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation: implications for use of implantable defibrillator. Circulation. 1995;91:1996-2001.
15. Marchlinski FE, Callans DJ, Gottlieb CD, et al. Benefits and lessons learned from stored electrogram information in implantable defibrillators. J Cardiovasc Electrophysiol. 1995;6:832-851.
16. Lang DJ, Swanson DK. Safety margin for defibrillation. In: Alt E, Klein H, Griffin JC, eds. The Implantable Cardioverter/Defibrillator. Berlin: Springer-Verlag; 1992:272-279.
17. Jones JL, Milne KB. Dysfunction and safety factor strength-duration curves for biphasic defibrillator waveforms. Am J Physiol. 1994;266: H263-H271.
18. Tokano T, Bach D, Chang J, et al. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol. 1998;9:791-797.
19. Yabe S, Smith WM, Daubert JP. Conduction disturbances caused by high current density electric fields. Circ Res. 1990;66:1190-1203.
20. Venditti FJ Jr, John RM, Hull M, et al. Circadian variation in defibrillation energy requirements. Circulation. 1996;94:1607-1612.
21. Glikson M, Trusty JM, Grice SK, et al. A stepwise testing protocol for modern implantable cardioverter-defibrillator systems to prevent pacemaker-implantable cardioverter-defibrillator interactions. Am J Cardiol. 1999;83:360-366.
22. Glotzer TV, Gordon M, Sparta M, et al. Electromagnetic interference from a muscle stimulation device causing discharge of an implantable cardioverter defibrillator: epicardial bipolar and endocardial bipolar sensing circuits are compared. Pacing Clin Electrophysiol. 1998;21: 1996-1998.
23. Natale A, Sra J, Axtell K, et al. Undetected ventricular fibrillation in transvenous implantable cardioverter-defibrillators: prospective comparison of different lead system-device combinations. Circulation. 1996; 93:91-98.
24. Taneja T, Goldberger J, Parker MA, et al. Reproducibility of ventricular fibrillation characteristics in patients undergoing implantable cardioverter defibrillator implantation. J Cardiovasc Electrophysiol. 1997;8: 1209-1217.
25. Jung M, Manz M, Moosdorf R, et al. Failure of an implantable cardioverter-defibrillator to redetect ventricular fibrillation in patients with a nonthoracotomy lead system. Circulation. 1992;86:1217-1222.
26. Bardy G, Yee R, Jung W. Multicenter experience with a pectoral unipolar implantable defibrillator. J Am Coll Cardiol. 1996;28:400-410.